Timeline
Last
$105.63
+0.17 (0.16%)
24HR+0.2%
1W-2.2%
1M+10.5%
1Y-19.2%
Valuation
- Market Cap
- $182.8B
- Enterprise Value
- $213.1B
- P/E (TTM)
- 34.18x
- Forward P/E
- 17.42x
- Price / Sales
- 3.92x
- EV / EBITDA
- 18.25x
Cash Flow
- Operating Cash Flow
- $9.9B
- Free Cash Flow
- $7.2B
- FCF Margin
- 15.5%
- Cash Conversion
- 72.8%
- Cash / Share
- $3.2
Margins & Growth
- Gross Margin
- 56.8%
- Operating Margin
- 14.7%
- EBITDA Margin
- 25.1%
- Net Margin
- 11.6%
- Revenue Growth
- 13.0%
- Earnings Growth
- -47.5%
Balance Sheet
- Total Cash
- $5.6B
- Total Debt
- $32.7B
- Net Cash
- -$27.1B
- Debt / Equity
- 0.63x
- Current Ratio
- 1.38x
- Quick Ratio
- 0.80x
Returns & Ownership
- Return on Assets
- 5.3%
- Return on Equity
- 10.6%
- Dividend Yield
- 2.4%
- Payout Ratio
- 79.0%
- Beta
- 0.58
- Institutional Ownership
- 82.7%
Latest EPS$1.31+0.0% surprise
Beat rate100%4 print streak
Avg surprise+0.0%vs consensus
Next printOct 14, 2026EPS $1.42
Quarterly EPS vs consensus
4 quarters Actual ConsensusLabels: beat $ · YoY %Revisions 50 up / 16 down
Earnings transcripts
Read management commentary and analyst Q&A.
No transcript dates are available yet for this ticker.
Forward estimates
Consensus expectations and estimate momentum.
PeriodEPSRevenueGrowth
0QSep 2026
$1.42$13.0B+9.2%+1QDec 2026
$1.64$13.5B+9.2%0YDec 2026
$5.52$50.3B+7.1%+1YDec 2027
$6.06$54.6B+9.9%Primary research
Recent company filings
Jump directly to earnings releases, quarterly reports, and material updates.
10-QPeriodic Financial Reports2026-07-288-KCorporate Changes & Voting Matters2026-07-1610-QPeriodic Financial Reports2026-04-298-KCorporate Changes & Voting Matters2026-04-278-KCorporate Changes & Voting Matters2026-04-178-KCorporate Changes & Voting Matters2026-04-168-KCorporate Changes & Voting Matters2026-03-098-KCorporate Changes & Voting Matters2026-02-2610-KPeriodic Financial Reports2026-02-208-KCorporate Changes & Voting Matters2026-01-228-KCorporate Changes & Voting Matters2025-12-128-KCorporate Changes & Voting Matters2025-11-21
ABT stock research · Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic c…
| Last price | $105.6 |
|---|---|
| Day change | +0.17 (0.16%) |
| Market cap | $182.8B |
| P/E (TTM) | 34.18x |
| Sector | Healthcare |
| Industry | Medical Devices |